{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T23:03:09Z","timestamp":1784502189978,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371092"],"award-info":[{"award-number":["82371092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2510802"],"award-info":[{"award-number":["2024YFC2510802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04365-7","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:24:42Z","timestamp":1779445482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A sequentially targeted and pathology-responsive nanoplatform for synergistic treatment of dry eye disease via concurrent anti-inflammation and mitochondrial ROS scavenging"],"prefix":"10.1186","volume":"24","author":[{"given":"Liandi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilian","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"4365_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1056\/NEJMra1407936","volume":"378","author":"JA Clayton","year":"2018","unstructured":"Clayton JA. Dry Eye. N Engl J Med. 2018;378:2212\u201323.","journal-title":"N Engl J Med"},{"key":"4365_CR2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jama.2021.19963","volume":"327","author":"FE Hakim","year":"2022","unstructured":"Hakim FE, Farooq AV. Dry eye disease: an update in 2022. JAMA. 2022;327:478\u20139.","journal-title":"JAMA"},{"key":"4365_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jconrel.2019.10.039","volume":"315","author":"F Yu","year":"2019","unstructured":"Yu F, Zheng M, Zhang AY, Han Z. A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease. J Control Release. 2019;315:40\u201354.","journal-title":"J Control Release"},{"key":"4365_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106206","volume":"175","author":"HB Mohamed","year":"2022","unstructured":"Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sci. 2022;175:106206.","journal-title":"Eur J Pharm Sci"},{"key":"4365_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202200435","volume":"9","author":"S Li","year":"2022","unstructured":"Li S, Lu Z, Huang Y, Wang Y, Jin Q, Shentu X, et al. Anti-oxidative and anti-inflammatory micelles: break the dry eye vicious cycle. Adv Sci. 2022;9:e2200435.","journal-title":"Adv Sci"},{"key":"4365_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10010028","volume":"10","author":"RD Bachu","year":"2018","unstructured":"Bachu RD, Chowdhury P, Al-Saedi ZHF, Karla PK, Boddu SHS. Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018;10:28.","journal-title":"Pharmaceutics"},{"key":"4365_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02503-7","volume":"22","author":"Y Xia","year":"2024","unstructured":"Xia Y, Zhang Y, Du Y, Wang Z, Cheng L, Du Z. Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage. J Nanobiotechnology. 2024;22:233.","journal-title":"J Nanobiotechnology"},{"key":"4365_CR8","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1167\/iovs.11-9417","volume":"53","author":"KS Na","year":"2012","unstructured":"Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012;53:5443\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4365_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bcp.2011.11.013","volume":"83","author":"CH Tang","year":"2012","unstructured":"Tang CH, Tsai CC. CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras\/Raf\/MEK\/ERK\/NF-kappaB signaling pathway. Biochem Pharmacol. 2012;83:335\u201344.","journal-title":"Biochem Pharmacol"},{"key":"4365_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01881","volume":"10","author":"Z Ji","year":"2019","unstructured":"Ji Z, Wu S, Xu Y, Qi J, Su X, Shen L. Obesity promotes EAE through IL-6 and CCL-2-mediated T cells infiltration. Front Immunol. 2019;10:1881.","journal-title":"Front Immunol"},{"key":"4365_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0796-z","volume":"19","author":"X Sun","year":"2017","unstructured":"Sun X, Glynn DJ, Hodson LJ, Huo C, Britt K, Thompson EW, et al. CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model. Breast Cancer Res. 2017;19:4.","journal-title":"Breast Cancer Res"},{"key":"4365_CR12","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1111\/aos.13526","volume":"96","author":"S Seen","year":"2018","unstructured":"Seen S, Tong L. Dry eye disease and oxidative stress. Acta Ophthalmol. 2018;96:e412\u201320.","journal-title":"Acta Ophthalmol"},{"key":"4365_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137141","volume":"282","author":"C Zheng","year":"2024","unstructured":"Zheng C, Chen F, Yang F, Li Z, Yi W, Chen G, et al. Myocardial cell mitochondria-targeted mesoporous polydopamine nanoparticles eliminate inflammatory damage in cardiovascular disease. Int J Biol Macromol. 2024;282:137141.","journal-title":"Int J Biol Macromol"},{"key":"4365_CR14","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1039\/D0BM01070G","volume":"8","author":"J Hu","year":"2020","unstructured":"Hu J, Yang L, Yang P, Jiang S, Liu X, Li Y. Polydopamine free radical scavengers. Biomater Sci. 2020;8:4940\u201350.","journal-title":"Biomater Sci"},{"key":"4365_CR15","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6528\/abf4a9","author":"K Lin","year":"2021","unstructured":"Lin K, Gan Y, Zhu P, Li S, Lin C, Yu S, et al. Hollow mesoporous polydopamine nanospheres: synthesis, biocompatibility and drug delivery. Nanotechnology. 2021. https:\/\/doi.org\/10.1088\/1361-6528\/abf4a9.","journal-title":"Nanotechnology"},{"key":"4365_CR16","doi-asserted-by":"publisher","DOI":"10.21470\/1678-9741-2022-0251","volume":"38","author":"Y Hacanli","year":"2023","unstructured":"Hacanli Y, Aydin MS, Ersoz EK, Kankilic N, Koyuncu I, Guldur ME, et al. Protective effects of fuziline on dobutamine-induced heart damage in mice. Braz J Cardiovasc Surg. 2023;38:e20220251.","journal-title":"Braz J Cardiovasc Surg"},{"key":"4365_CR17","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/jcmm.14803","volume":"24","author":"CL Fan","year":"2020","unstructured":"Fan CL, Yao ZH, Ye MN, Fu LL, Zhu GN, Dai Y, et al. Fuziline alleviates isoproterenol-induced myocardial injury by inhibiting ROS-triggered endoplasmic reticulum stress via PERK\/eIF2alpha\/ATF4\/Chop pathway. J Cell Mol Med. 2020;24:1332\u201344.","journal-title":"J Cell Mol Med"},{"key":"4365_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jep.2016.10.052","volume":"194","author":"P Li","year":"2016","unstructured":"Li P, Lv B, Jiang X, Wang T, Ma X, Chang N, et al. Identification of NF-\u03baB inhibitors following Shenfu injection and bioactivity-integrated UPLC\/Q-TOF-MS and screening for related anti-inflammatory targets in vitro and in silico. J Ethnopharmacol. 2016;194:658\u201367.","journal-title":"J Ethnopharmacol"},{"key":"4365_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01896-1","volume":"21","author":"J Yang","year":"2023","unstructured":"Yang J, Wang M, Zheng S, Huang R, Wen G, Zhou P, et al. Mesoporous polydopamine delivering 8-gingerol for the target and synergistic treatment to the spinal cord injury. J Nanobiotechnology. 2023;21:192.","journal-title":"J Nanobiotechnology"},{"key":"4365_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/09637480903292601","volume":"61","author":"MK Roy","year":"2010","unstructured":"Roy MK, Koide M, Rao TP, Okubo T, Ogasawara Y, Juneja LR. ORAC and DPPH assay comparison to assess antioxidant capacity of tea infusions: relationship between total polyphenol and individual catechin content. Int J Food Sci Nutr. 2010;61:109\u201324.","journal-title":"Int J Food Sci Nutr"},{"key":"4365_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ph17070941","author":"M Newman","year":"2024","unstructured":"Newman M, Connery H, Kannan S, Gautam A, Hammamieh R, Chakraborty N, et al. Fentanyl Overdose Causes Prolonged Cardiopulmonary Dysregulation in Male SKH1 Mice. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17070941.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4365_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.intimp.2018.09.011","volume":"65","author":"Q An","year":"2018","unstructured":"An Q, Yan W, Zhao Y, Yu K. Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis. Int Immunopharmacol. 2018;65:119\u201328.","journal-title":"Int Immunopharmacol"},{"key":"4365_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jconrel.2023.11.053","volume":"365","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhou T, Qi Y, Li Y, Zhang Y, Zhao Y, et al. Engineered assemblies from isomeric pentapeptides augment dry eye treatment. J Control Release. 2024;365:521\u20139.","journal-title":"J Control Release"},{"key":"4365_CR24","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10753-024-02130-2","volume":"48","author":"J Tian","year":"2025","unstructured":"Tian J, Li Y, Gao S, Wang Y, Li H, Wei X, et al. atRA attenuates high salt-driven EAE mainly through suppressing Th17-like regulatory T cell response mediated by the inhibition of IL-23R signaling pathway. Inflammation. 2025;48:1403\u201319.","journal-title":"Inflammation"},{"key":"4365_CR25","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.2147\/JIR.S508098","volume":"18","author":"X Wu","year":"2025","unstructured":"Wu X, Li X, Chai Y, Tian Y, Wang H, Li X, et al. Cordyceps sinensis reduces inflammation and protects BEAS-2B cells from LPS-induced THP-1 cell injury. J Inflamm Res. 2025;18:4143\u201356.","journal-title":"J Inflamm Res"},{"key":"4365_CR26","doi-asserted-by":"publisher","first-page":"470","DOI":"10.7150\/thno.14184","volume":"6","author":"W Tao","year":"2016","unstructured":"Tao W, Zeng X, Wu J, Zhu X, Yu X, Zhang X, et al. Polydopamine-based surface modification of novel nanoparticle-aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effects. Theranostics. 2016;6:470\u201384.","journal-title":"Theranostics"},{"key":"4365_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.freeradbiomed.2019.05.019","volume":"139","author":"H Xu","year":"2019","unstructured":"Xu H, Li C, Mozziconacci O, Zhu R, Xu Y, Tang Y, et al. Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis. Free Radic Biol Med. 2019;139:70\u20139.","journal-title":"Free Radic Biol Med"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04365-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T22:56:07Z","timestamp":1784501767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04365-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4365"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04365-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed subject to relevant guidelines and regulations and received approval from the Animal Experimental Committee of Renji Hospital, Shanghai Jiao Tong University School of Medicine (RJ2024-129B).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"674"}}